{
    "nct_id": "NCT04473781",
    "official_title": "Prospective Study of Interstitial Brachytherapy for Unresectable/Unablatable T1b/T2a Renal Masses",
    "inclusion_criteria": "* Elected to undergo interstitial brachytherapy as part of conventional treatment for renal cell carcinoma\n* Biopsy proven renal cell carcinoma\n* No definitive evidence of locally advanced (nodal or tumor thrombus) or distant (metastatic) disease\n* Lesion size (maximal dimension) of 4 to 10 cm\n* Patient not a candidate for curative surgery (unwilling or unable to pursue surgery)\n* Lesion cannot be reliably treated with ablative techniques\n* Entire lesion able to be treated adequately by brachytherapy per radiation oncologist\n* Tumor predominantly solid (~ > 80%)\n* Lesion that has been observed for >= 6 months with demonstrable growth rate anticipated to be >= 4 mm/year by same imaging modality\n* Renal tumor that is amenable to percutaneous access for interstitial renal brachytherapy (Institutional Review Board [IRB])\n* Hemoglobin > 9\n* Absolute neutrophil count (ANC) >= 1500/uL (microliter)\n* Platelets >= 100,000/uL\n* Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3.0 upper limit of normal (ULN)\n* Total bilirubin =< ULN\n* A competent immune system\n* Estimated glomerular filtration rate (eGFR) >= 30\n* Good performance status (Eastern Cooperative Oncology Group [ECOG]) < 2\n* Understanding and willingness to provide consent\n* No prior systemic treatment for kidney cancer\n* Women of childbearing potential must have negative pregnancy test at start of therapy\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Presence of an active, untreated, non-renal malignancy\n* Uncontrolled medical illness including infections, hypertension, arrhythmias, heart failure, or myocardial infarction within 6 months\n* History of bleeding diathesis or recent bleeding episode\n* Need for urgent treatment of renal cancer due bleeding, pain, or paraneoplastic syndrome\n* Prior surgery or radiation therapy to the operative site\n* Unwillingness to undergo clinical and laboratory monitoring and/or imaging studies",
    "miscellaneous_criteria": ""
}